Cite
HARVARD Citation
Alkabbani, W. et al. (2021). Sodium/Glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis: An Example of Complementary Evidence for Rare Adverse Events. American journal of epidemiology. 190 (8), pp. 1572-1581. [Online].